These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Advanced case of PKDL due to delayed treatment: A rare case report. Topno RK, Rabi Das VN, Kumar M, Madhukar M, Pandey K, Verma N, Agrawal K, Lal CS, Siddiqui NA, Bimal S, Das P. PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008052. PubMed ID: 32203500 [Abstract] [Full Text] [Related]
5. Miltefosine Induced Reduced Male Fertility Capacity after Treatment of Post Kala-azar Dermal Leishmaniasis, Bangladesh. Basher A, Rashid MM, Habibullah AM, Nath R, Akter D, Chowdhury IH, Azim A, Nath P, Faiz MA. Mymensingh Med J; 2019 Apr; 28(2):328-332. PubMed ID: 31086147 [Abstract] [Full Text] [Related]
10. Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol. Mondal D, Hasnain MG, Hossain MS, Ghosh D, Ghosh P, Hossain H, Baker J, Nath R, Haque R, Matlashewski G, Hamano S. BMJ Open; 2016 May 17; 6(5):e010050. PubMed ID: 27188804 [Abstract] [Full Text] [Related]
11. Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis. Ramesh V, Dixit KK, Sharma N, Singh R, Salotra P. J Infect Dis; 2020 Feb 03; 221(4):608-617. PubMed ID: 31854451 [Abstract] [Full Text] [Related]
12. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India. Singh RP, Picado A, Alam S, Hasker E, Singh SP, Ostyn B, Chappuis F, Sundar S, Boelaert M. Trop Med Int Health; 2012 Nov 03; 17(11):1345-8. PubMed ID: 22882665 [Abstract] [Full Text] [Related]
15. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. Bhandari V, Kulshrestha A, Deep DK, Stark O, Prajapati VK, Ramesh V, Sundar S, Schonian G, Dujardin JC, Salotra P. PLoS Negl Trop Dis; 2012 Nov 03; 6(5):e1657. PubMed ID: 22629478 [Abstract] [Full Text] [Related]
16. Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL). Wijnant GJ, Moulik S, Chatterjee K, Das NK, de la Flor R, Van Bocxlaer K, Croft SL, Chatterjee M. Exp Parasitol; 2024 Feb 03; 257():108687. PubMed ID: 38114040 [Abstract] [Full Text] [Related]
17. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis. Hasnain G, Shomik MS, Ghosh P, Rashid MO, Hossain S, Hamano S, Mondal D. Am J Trop Med Hyg; 2016 Dec 07; 95(6):1383-1385. PubMed ID: 27672208 [Abstract] [Full Text] [Related]